BRILINTA
BRILINTA
Approved
DIN Number
02455005
Drug Class
Human
Market Date
Jun 13, 2016
Company
HC
astrazeneca canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02455005
AIG Number0152934002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AC24 TICAGRELOR
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification20:12.18
Health Canada Classification
ACTIVE INGREDIENTS (1)
TICAGRELORActive
Strength: 60 MG
Monograph: TICAGRELOR